betway体育:亚洲药物研发创新峰会
会议时间： betway体育:-03-13至 betway体育:-03-14
会议地点： 上海
电话：021-31602153
传真：
联系人：市场部
Email： Marketing@wbfgroup.com
联系地址：上海兴荣温德姆大酒店
会议网址：www.aprdic.com
Asia Pharma R&D Innovation betway体育: is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CROs, academic institutions, technology and solution provider, investors and all the way down to other industrial stakeholders to assess the latest industrial trends, R&D strategies, partnership models and technology advancements in China and Asia.
This is the largest annual pharmaceutical R&D gathering in China featuring multiple conferences, summits and seminars that cover the entire value chain of the pharma R&D. Asia Pharma R&D Innovation betway体育: will show you how you can access the important markets in Asia that matters most to your R&D strategies. Our aim is to promote global and regional deal making between pharmas, biotechs and academics in China and across other Asian countries and to leverage technologies to your advantage in promising drug discovery, screening, safety, clinical trials and R&D activities in the region.
Key topics will cover:
• Asia’s R&D landscape from big pharma’s eyes
• How Collaboration is Driving Innovation in Research & Development ?
• Boosting Chinas new Drug Research and Development to Enhance Global Competitiveness
•Regulatory Data Protection, Patent Linkage and Patent Term Extension in New Drug Discovery and Development
•Tapping into Funding and Investment Opportunities on New Drug Discovery and Development in China
• Chinese BioPharma R&D Collaboration Opportunities and Development Models Innovation in the Future
• Case study of drug R&D and Oncology Therapeutic Focus
• Excellence in services – Technology showcase
•Omics,New Biomarker Discovery and Precision Medicine Development,Novel Technologies for Drug Discovery
•Clinical Trials Innovation
•Biomarker & Real World Data Based Decision Making in Drug Development
•Flexible and Efficient Data Management and Statistical Analysis
•Model-Driven Combined Design in Phase I/II Clinical Trials
On behalf of the committee, we sincerely hope primary discussions, topics and invitees would come across your scientific and strategic interests and the whole summit will be consisted of keynote speeches, panel/roundtable discussions, open Q&A sessions, booth and poster exhibition and guided networking sessions for all professionals and management who are working for the Biopharma industry in Asia
Who Should Attend？
More than 300 participants are expected to attend “The 3rd Asia Pharma R&D Innovation Conference betway体育:, attracting the strong contingent throughout the Asia Pacific, USA and Europe. To breakdown, the participants will mainly come from:
By Attendees:
By Attendees:
Chief Executive Officer
Chief Medical Officer
Chief Scientific Officer
SVP, VP, Head, Director of
Research and Development
R&D Business Development
Medical Affairs
Outsourcing and Externalization
Oncology/CNS/Diabetes Research
Biomarker and Translational Research
Licensing and Partnership
Clinical Trials
By Industry:
Animal Studies Services
Bioparks
Pharma/Biopharmas
Biotechs
Clinical Data Management
Clinical Research / Clinical Trials Services
Cold Chain Solutions
Compliance and Validation Services
Contract Research Services
Database / Data Mining
Drug Discovery Support Software
Electronic Data Capturing Systems
Genomic Research Tools and Equipments
High Performance Computing
Imaging Systems/Image Analysis
Legal Companies
Mass Spectrometry Analysis
Microarray Instruments
Private Equity
Proteomics Research Tools and Reagents
Protein/DNA Analyzing Software
Research Equipment and Consumables
Recruitment AgenciesStem Cell Research Technologies
Technology Transfer/Licensing Services
Venture Capital Firms
Why you can not miss Asia
Pharma R&D Innovation betway体育:?
1.Develop new business models in betway体育: and beyond for pharma R&D geared toward cost efficiency and ROI improvement
2.Navigate Asia market trends for heavily invested therapeutics areas: oncology, CNS and metabolic diseases
3.Lay foundations for effective partnership with top China CRO,biotech and academia
4.Hear how government initiatives in China 13th 5 years’ planbenefit for your research projects in China
5.Learn from best practice in managing research, balancingcosts, risk and profits
6.Explore mass in-licensing opportunities in Asia emerging markets in response to new world R&D order
7.Meet 1 on 1 with your end buyers who plan to outsource R&D to Asia for their R&D in Europe or US
8.Build right contacts in big pharma for your early stage discoveries and identify how deals can be done in Asia
9.Identify late stage opportunities in Asia to gaincompetitiveness when facing patent cliff in betway体育:
Event Name: The 3rd Annual Asia Pharma R&D Innovation Conference betway体育:
Date: March 13th to 14th,betway体育:
Venue: Wyndham Bund East Shanghai,China
Contact Person:Marketing Department
Direct Line:86 21 31602153
Email:Marketing@wbfgroup.com
Website: www.aprdic.com
betway体育: 亚洲药物研发创新峰会
来自世界各地的医药和生物科技公司的专家和决策者们将于betway体育:年3月13日至14日齐聚于届时于上海举行的"betway体育:亚洲药物研发创新峰会" 来探讨如何更有效地发掘亚洲这个正在不断成长壮大的医药市场。
随着我国对新药研发需求的逐步释放，医药行业改革已步入深水区。密集出台的政策逐渐改变医药市场格局，新药研发提至战略高地，仿制药创新升级被落到实处，辅助用药纳入严格监管，药品生产工艺自查、飞检迫在眉睫，中药审批程序由繁化简，医药行业形势骤变，吹响了betway体育:医药行业由销售驱动型转向研发驱动型的号角。
大会将邀请来自全球的药企、生物技术公司、科研院所等相关机构负责研发、合作的高管、专家及决策者，职位包括：研发、临床、商业发展、公共关系、授权、政策管理等共同探讨当前全球研发趋势、研发策略、创新能力建设及合作机遇等热点话题，旨在为全球研发从业者建立一个高效的交流合作平台，优化研发战略创新性，把握研发趋势前瞻性，强化流程管理科学性，深化外部合作的开放性，共同推动亚洲医药研发效率及创新能力的提高，立足亚洲走向世界！
如果您期望与亚洲医药和生物制药领域的决策者们会面及交流学习，这里将是您唯一正确的选择。令您及您的团队始终处于亚洲生物制药发展最前沿，尽在betway体育:年3月13-14日的第三届亚洲医药研发创新国际峰会，期待您的参与！
届时峰会将有国际主题演讲，产业及学术报告，众多交流机会，将为高端科技及商业探讨打造一个互动的平台。我们欢迎阁下致电我们获得更多信息及赞助、展览机会，86-21-31602153获取更多信息，请登录我们的会议网站www.aprdic.com 或把您的问题发送至我们电邮marketing@wbfgroup.com 。
会议名称:betway体育:亚洲医药研发创新国际峰会
日期：betway体育:年3月13日-3月14日
地点：上海兴荣温德姆大酒店
联系：市场部
报名电话：+86-21-31602153
邮箱：Marketing@wbfgroup.com
会议官网：www.aprdic.com
2、若您发现信息有误或需要信息发布，请联系：
010-50830819；邮箱：meeting@scitoday.cn.
